Multifactorial etiology of cervical cancer: A hypothesis

MedGenMed Medscape General Medicine

Volumn 7, Issue 4, 2005, Pages

  Haverkos, Harry W ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COAL TAR; ORAL CONTRACEPTIVE AGENT; VIRUS DNA;

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CHEMICAL CARCINOGENESIS; CIGARETTE SMOKING; COOKING; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MIDDLE EAST; NONHUMAN; NUTRITIONAL STATUS; ONCOVIRINAE; RISK ASSESSMENT; RISK FACTOR; SOUTH AFRICA; SQUAMOUS CELL CARCINOMA; STRAIN DIFFERENCE; SUPERINFECTION; UTERINE CERVIX CANCER; VAGINAL LAVAGE; VIRUS CARCINOGENESIS; VIRUS STRAIN;

EID: 29144480981     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Anonymous. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum. 1995;94:1-379.
2. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342-350.
3. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-19.
4. Herrington CS. Do HPV-negative cervical carcinomas exist? - Revisited. J Pathol. 1999;189:1-3.
5. Franco EL, Rohan TE, Villa LL. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst. 1999;91:506-511.
6. Huber E, Vlasny D, Jeckel S, Stubenrauch F, Iftner T. Gene profiling of cottontail rabbit papillomavirus-induced carcinomas indentifies upregulated genes directly involved in stroma invasion as shown by small interfering RNA-mediated gene silencing. J Virol. 2004;78:7478-7489.
7. Garrett LR, Perez-Reyes N, Smith PP, McDougall JK. Interaction of HPV-18 and nitrosomethylurea in the induction of squamous cell carcinoma. Carcinogenesis. 1993;14:329-332.
8. Schiffman M, Castle PE. Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med. 2003;127:930-934.
9. Shields TS, Brinton LA, Burk RD, et al. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus. Cancer Epidemiol Biomarkers Prev. 2004;13:1574-1582.
10. Haverkos HW. Viruses, chemicals and co-carcinogenesis. Oncogene. 2004;23:6492-6499.
11. Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol. 2005; 32(Suppl):16-24.
12. zur Hausen H. Human genital cancer: Synergism between two virus infections or synergism between a virus infection and initiating events? Lancet. 1982;2:1370-1372.
13. Rous P, Beard JW. The progression to carcinoma of virus-induced rabbit papillomas (Shope). J Exp Med. 1934;60:741-766.
14. Rous P, Kidd JG. The carcinogenic effect of a papilloma virus on the tarred skin of rabbits: I. Description of the phenomenon. J Exp Med. 1938;67:399-428.
15. Rogers S, Rous P. Joint action of a chemical carcinogen and a neoplastic virus to induce cancer in rabbits: results of exposing epidermal cells to a carcinogenic hydrocarbon at time of infection with the Shope papilloma virus. J Exp Med. 1951;93:459-486.
16. Rous P. Transmission of a malignant new growth by means of a cell-free filtrate. JAMA. 1911;56:198.
17. Rous P. Viruses and tumour causation. An appraisal of present knowledge. Nature. 1965;207:457-463.
18. Ferlay J, Bray R, Pisani P, Parkin DM. Globocan 2000: Cancer incidence, mortality and prevalence worldwide, version 1.0. IARC Cancer Base, No. 5. Lyon: IARC Press; 2001. Available at: http://www-dep.iarc.fr/dataava/dataicon.htm.
19. Steckley SL, Pickworth WB, Haverkos HW. Cigarette smoking and cervical cancer: Part II: a geographic variability study. Biomed Pharmacother. 2003;57:78-83.
20. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
21. US Mortality Public Use Data Tapes 1960-2000, US Mortality Volumes 1930-1959, National Center for Health Statistics, Centers for Disease Control and Prevention; 2003.
22. Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence - SEER 9 Regs Public-USE, Nov 2003 Sub (1973-2001), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2004, based on the November 2003 submission. Available at: www.seer.cancer.gov.
23. Rigoni-Stern D. 'Fatti statistici alle mallattie cancerose che servirono di base alle poche cose dal dott' [Italian]. F Prog Patol Terap. 1842; 2:499-517.
24. Armstrong BK, Munoz N, Bosch FX. Epidemiology of cancer of the cervix. In: Coppleson M, ed. Gynecologic Oncology, 2nd ed. Edinburgh: Churchill Livingstone; 1992: 11-28.
25. zur Hausen H, Meinhof W, Schreiber W, Bornkamm GW. Attempts to detect virus-specific DNA sequences in human tissues. I. Nucleic acid hybridizations with complementary RNA of human wart virus. Int J Cancer. 1974;13: 650-656.
26. zur Hausen H. Oncogenic herpesviruses. Biophys Biochim Acta.1975;417:25-53.
27. zur Hausen H, Gissman L, Steiner W, Dippold W, Dreger J. Human papillomaviurus and cancer. Bibl Haematol. 1975; 43:569-571.
28. zur Hausen H. Condyloma acuminata and human genital cancer. Cancer Res. 1976;36:794.
29. Durst M, Gissmann L, Ikenberg H, zur Hausen H. A new type of papillomavirus DNA from a cervical carcinoma and its prevalence in genital cancer biopsies from different geographic regions. Proc Natl Acad Sci USA. 1983;80:3812-3815.
30. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer EMBO J. 1984;3:1151-1157.
31. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992;327:1272-1278.
32. Ho GYF, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 1995;87:1365-1371.
33. Bosch FX, Munoz N, de Sanjose S, et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer. 1992;52:750-758.
34. Ferrera A, Velema JP, Figueroa M, et al. Co-factors related to the causal relationship between human papilloma virus and invasive cervical cancer in Honduras. Int J Epidemiol. 2000;29: 817-825.
35. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995;87:796-802.
36. Wheeler CM, Parmenter CA, Hunt WC, et al. Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center. Sex Transm Dis. 1993;20:286-289.
37. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338:423-428.
38. Richardson H, Kelsall G, Tellier P, et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev. 2002;12:485-490.
39. zur Hausen H. Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events. Lancet. 1982;2:1370-1372.
40. Hildesheim A, Mann V, Brinton LS, Szklo M, Reeves WC, Rawls WE. Herpes simplex virus type 2: a possible interaction with human papillomavirus types 16/18 in the development of invasive cervical cancer. Int J Cancer. 1991;49:335-340.
41. Daling JR, Madeleine MM, McKnight B, et al. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomarkers Prev. 1996;5:541-548.
42. Frenkel N, Roizman B, Cassai E, Nahmias A. A DNA fragment of herpes simplex 2 and its trancription in human cervical cancer tissue. Proc Natl Acad Sci USA. 1972;69:3784-3789.
43. Mendis LN, Best JM, Banatvala JE. Class-specific antibodies (IgG and IgA) to membrane antigens of Herpes simplex type 2-infected cells in patients with cervical dysplasia and neoplasia. Int J Cancer. 1981;27:669-677.
44. Smith JS, Herrero R, Bosetti C, et al. International Agency for Research on Cancer Multicentric Cervical Cancer Study Group. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst. 2002;94:1604-1613.
45. Tran-Thanh D, Provencher D, Koushik A, et al. Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer fo the uterine cervix. Am J Obstet Gynecol. 2003;188:129-134.
46. Melicow MM. Percivall Pott (1713-1788): 200th anniversary of first report of occupation-induced cancer scrotum in chimney sweeps (1775). Urology. 1975;6:745-749.
47. Levitz JS, Bradley TP, Golden AL. Overview of smoking and all cancers. Med Clin North Am. 2004;88:1655-1675, xiii.
48. Zackheim HS. Should coal tar products carry cancer warnings? Cutis. 2004;73:333-334.
49. Report on Carcinogens, Eleventh Edition; U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program.
50. Smith FR. Etiologic factors in carcinoma of the cervix. Am J Obstet Gynecol. 1931;21:18-25.
51. Lombard HL, Potter EA. Epidemiologic aspects of cancer of the cervix: II. Hereditary and environmental factors. Cancer. 1950;3:960-968.
52. Rotkin ID. Epidemiology of cancer of the cervix: 3: Sexual characteristics of a cervical cancer population. Am J Public Health Nations Health. 1967;57:815-829.
53. Zhang J, Thomas AG, Leybovich E. Vaginal douching and adverse health effects: A meta-analysis. Am J Public Health. 1997;87:1207-1211.
54. Graham S, Schotz W. Epidemiology of cancer of the cervix in Buffalo, New York. J Natl Cancer Inst. 1979;63:23-27.
55. Peters RK, Thomas D, Hagan DG, Mack TM, Henderson BE. Risk factors for invasive cervical cancer among Latinos and non-Latinos in Los Angeles County. J Natl Cancer Inst. 1986;77:1063-1077.
56. Brinton LA, Hamman RF, Huggins GR, et al. Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J Natl Cancer Inst. 1987;79:23-30.
57. Gardner JW, Schuman KL, Slattery ML, Sanborn JS, Abbot TM, Overall JC Jr. Is vaginal douching related to cervical carcinoma? Am J Epidemiol. 1991;133:368-375.
58. Stone KM, Zaidi A, Rosero-Bixby L, et al. Sexual behavior, sexually transmitted diseases, and risk of cervical cancer. Epidemiology. 1995;6:409-414.
59. Herrero R, Brinton LA, Reeves WC, at el. Sexual behavior, venereal diseases, hygiene practices, and invasive cervical cancer in a high-risk population. Cancer. 1990;65:380-386.
60. Hildesheim A, Herrero R, Castle PE, et al. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer. 2001;84:1219-1226.
61. Castle PE, Wacholder S, Lorincz AT, et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst. 2002;94:1406-1414.
62. Winkelstein W Jr, Sacks ST, Ernster VL, Selvin S. Correlation of incidence rates for selected cancers in the nine areas of the Third National Cancer Survey. Am J Epidemiol. 1977;105:407-409.
63. Winkelstein W Jr. Smoking and cancer of the uterine cervix: hypothesis. Am J Epidemiol. 1977;106:257.
64. Haverkos HW, Soon G, Steckley SL, Pickworth W. Cigarette smoking and cervical cancer: Part I: A meta-analysis. Biomed Pharmacother. 2003;57:67-77.
65. Trimble CL, Genkinger JM, Burke AE, et al. Active and passive cigarette smoking and the risk of cervical neoplasia. Obstet Gynecol. 2005;105:174-181.
66. Prokopczyk B, Cox JE, Hoffmann D, Waggoner SE. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst. 1997;89:868-873.
67. Velema JP, Ferrera A, Figueroa M, et al. Burning wood in the kitchen increases the risk of cervical neoplasia in HPV-infected women in Honduras. Int J Cancer. 2002;97:536-541.
68. Southam CM. The complex etiology of cancer. Cancer Res. 1963;23:1105-1115.
69. Papanicolaou GN, Traut HF. 'The diagnostic value of vaginal smears in carcinoma of the uterus. Am J Obstet Gynecol. 1941;42:193-206.
70. Traut H. Obituary for George N. Papanicolaou, MD, PhD. Oncology. 1963;16:351-353.
71. de Villiers EM, Fauquet C, Broker TR, Bernard RU, zur Hausen H. Classification of papillomaviruses. Virology. 2004;324:17-27.